Editorial Commentary: Short‐Course Treatment of Community‐Acquired Pneumonia

This publication has 9 references indexed in Scilit:

• High‐Dose, Short‐Course Levofloxacin for Community‐Acquired Pneumonia: A New Treatment Paradigm
  Clinical Infectious Diseases, 2003
• Resolution of ventilator-associated pneumonia: Prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome*
  Critical Care Medicine, 2003
• Pharmacodynamics of 750 mg and 500 mg doses of levofloxacin against ciprofloxacin-resistant strains of Streptococcus pneumoniae
  Diagnostic Microbiology and Infectious Disease, 2002
• Effect of Short-Course, High-Dose Amoxicillin Therapy on Resistant Pneumococcal Carriage
  JAMA, 2001
• Resolution of Infectious Parameters after Antimicrobial Therapy in Patients with Ventilator-associated Pneumonia
  American Journal of Respiratory and Critical Care Medicine, 2001
• Steady-State Plasma and Intrapulmonary Concentrations of Levofloxacin and Ciprofloxacin in Healthy Adult Subjects
  Chest, 2001
• Randomized, Multicentre Study of the Efficacy and Tolerance of Azithromycin versus Clarithromycin in the Treatment of Adults with Mild to Moderate Community-Acquired Pneumonia
  European Journal of Clinical Microbiology & Infectious Diseases, 1998
• A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin–clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome
  International Journal of Antimicrobial Agents, 1998
• Pharmacodynamics of Levofloxacin
  JAMA, 1998